Cardiovascular Journal of Africa: Vol 25 No 4(July/August 2014) - page 2

Whatever the stage
of hypercholesterolaemia
Your patient deserves
the yellow jersey
A molecule engineered for
superior performance from Team Cipla
1
• The first to market generic rosuvastatin
2
• Offering the complete dosage range
3
• No patient co-pay
3
Up to a
43%
saving vs the originator
4
References:
1. Jones PH et al. Comparison of the efficacy and safety of rosuvasorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial).Am J Cardiol 2003;92:152–160
2. IMS Data, July 2014 3. The Generics Dictionary, May/June 2014 4. Department of Health website
– referenced August 2014
S4 VUSOR 5
: Reg. No: 45/7.5/0310.
S4 VUSOR 10
: 45/7.5/0311.
S4 VUSOR 20
: 45/7.5/0312.
S4 VUSOR 40
: 45/7.5/0313.
Each tablet contains 5 mg, 10 mg, 20 mg or 40 mg of rosuvastatin respectively as rosuvastatin calcium. For full prescribing information see package insert.
DETAILS OF THE REGISTERED LICENCE HOLDER:
Watson Pharma No. 1 (Pty) Ltd, 1st Floor Block C, Sandton Close 1, Cnr 5th Street & Norwich Close, Sandown.
MARKETED BY:
Cipla Medpro (Pty) Ltd. Reg. No. 1995/004182/07,Building 9, Parc du Cap, Mispel Street, Bellville, 7530, RSA. Tel (021) 943 4200, Fax (021) 914 4699.
E-mail:
Website:
Customer Care: 080 222 6662
1 3,4,5,6,7,8,9,10,11,12,...68
Powered by FlippingBook